1. Drug product performance, in vitro;Sathe,2005
2. Current perspectives in dissolution testing of conventional and novel dosage forms;Azarmi;Int J Pharm,2007
3. Overall considerations;Hanson,1982
4. FDA SUPAC SS working group. 1997. Guidance for industry. Nonsterile semisolid dosage forms. Scale-up and postapproval changes: Chemistry, manufacturing and controls; in vitro release testing and in vivo bioequivalence documentation.
5. Topical and transdermal drug products;Ueda;Pharmacopeial Forum,2009